Global Fludeoxyglucose (18F) Radionuclide Injection Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 159233
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Medical Devices

Fludeoxyglucose (18F) radionuclide injection is radioactive substance used for diagnostic purpose with Positron Emission Tomography (PET).

Scope of the Report:

This report focuses on the Fludeoxyglucose (18F) Radionuclide Injection in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Advancement in radiopharmaceutical technologies along with more improve hardware and software of PET imaging are the primary factors driving the growth of Fludeoxyglucose (18F) Radionuclide Injection market.

United States is expected to dominate the global Fludeoxyglucose (18F) Radionuclide Injection market due to high healthcare infrastructure.

ter United States, Fludeoxyglucose (18F) Radionuclide Injection market is then followed by Europe and Asia-Pacific. Europe market is expected to grow due to rise in the number of manufacturing companies of Fludeoxyglucose (18F) Radionuclide Injection. In Asia-Pacific, India and China are expected to be major market owing to increasing geriatric population and cancer incidences.

The worldwide market for Fludeoxyglucose (18F) Radionuclide Injection is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Zevacor Pharma

Queen's PET Imaging

Triad Isotopes

NCM USA Bronx

Spectron MRC

Petnet Solutions

Shertech Laboratories

Precision Nuclear

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Cancer

Coronary Artery Disease

Others

Market Segment by Applications, can be divided into

Hospitals

Clinics

Diagnostics Center

There are 15 Chapters to deeply display the global Fludeoxyglucose (18F) Radionuclide Injection market.

Chapter 1, to describe Fludeoxyglucose (18F) Radionuclide Injection Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Fludeoxyglucose (18F) Radionuclide Injection, with sales, revenue, and price of Fludeoxyglucose (18F) Radionuclide Injection, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Fludeoxyglucose (18F) Radionuclide Injection, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Fludeoxyglucose (18F) Radionuclide Injection market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Fludeoxyglucose (18F) Radionuclide Injection sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Fludeoxyglucose (18F) Radionuclide Injection Introduction

1.2 Market Analysis by Type

1.2.1 Cancer

1.2.2 Coronary Artery Disease

1.2.3 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Clinics

1.3.3 Diagnostics Center

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Zevacor Pharma

2.1.1 Business Overview

2.1.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Zevacor Pharma Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Queen's PET Imaging

2.2.1 Business Overview

2.2.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Queen's PET Imaging Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Triad Isotopes

2.3.1 Business Overview

2.3.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Triad Isotopes Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 NCM USA Bronx

2.4.1 Business Overview

2.4.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 NCM USA Bronx Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Spectron MRC

2.5.1 Business Overview

2.5.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Spectron MRC Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Petnet Solutions

2.6.1 Business Overview

2.6.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Petnet Solutions Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Shertech Laboratories

2.7.1 Business Overview

2.7.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Shertech Laboratories Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Precision Nuclear

2.8.1 Business Overview

2.8.2 Fludeoxyglucose (18F) Radionuclide Injection Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Precision Nuclear Fludeoxyglucose (18F) Radionuclide Injection Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share in 2017

3.3.2 Top 6 Fludeoxyglucose (18F) Radionuclide Injection Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Fludeoxyglucose (18F) Radionuclide Injection Market Analysis by Regions

4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Regions

4.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Regions (2013-2018)

4.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Regions (2013-2018)

4.2 North America Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

4.3 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

4.5 South America Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

5 North America Fludeoxyglucose (18F) Radionuclide Injection by Countries

5.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Countries

5.1.1 North America Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Countries (2013-2018)

5.1.2 North America Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Countries (2013-2018)

5.2 United States Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

5.3 Canada Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

5.4 Mexico Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

6 Europe Fludeoxyglucose (18F) Radionuclide Injection by Countries

6.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Countries

6.1.1 Europe Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Countries (2013-2018)

6.2 Germany Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

6.3 UK Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

6.4 France Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

6.5 Russia Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

6.6 Italy Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

7 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection by Countries

7.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Countries (2013-2018)

7.2 China Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

7.3 Japan Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

7.4 Korea Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

7.5 India Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

8 South America Fludeoxyglucose (18F) Radionuclide Injection by Countries

8.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Countries

8.1.1 South America Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Countries (2013-2018)

8.1.2 South America Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

8.3 Argentina Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

8.4 Colombia Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

9 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection by Countries

9.1 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

9.3 UAE Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

9.4 Egypt Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

9.5 Nigeria Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

9.6 South Africa Fludeoxyglucose (18F) Radionuclide Injection Sales and Growth Rate (2013-2018)

10 Global Fludeoxyglucose (18F) Radionuclide Injection Market Segment by Type

10.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales and Market Share by Type (2013-2018)

10.1.2 Global Fludeoxyglucose (18F) Radionuclide Injection Revenue and Market Share by Type (2013-2018)

10.2 Cancer Sales Growth and Price

10.2.1 Global Cancer Sales Growth (2013-2018)

10.2.2 Global Cancer Price (2013-2018)

10.3 Coronary Artery Disease Sales Growth and Price

10.3.1 Global Coronary Artery Disease Sales Growth (2013-2018)

10.3.2 Global Coronary Artery Disease Price (2013-2018)

10.4 Others Sales Growth and Price

10.4.1 Global Others Sales Growth (2013-2018)

10.4.2 Global Others Price (2013-2018)

11 Global Fludeoxyglucose (18F) Radionuclide Injection Market Segment by Application

11.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Clinics Sales Growth (2013-2018)

11.4 Diagnostics Center Sales Growth (2013-2018)

12 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales, Revenue and Growth Rate (2018-2023)

12.2 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by Regions (2018-2023)

12.2.1 North America Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.2.2 Europe Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.2.3 Asia-Pacific Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.2.4 South America Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.2.5 Middle East and Africa Fludeoxyglucose (18F) Radionuclide Injection Market Forecast (2018-2023)

12.3 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by Type (2018-2023)

12.3.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Forecast by Type (2018-2023)

12.3.2 Global Fludeoxyglucose (18F) Radionuclide Injection Market Share Forecast by Type (2018-2023)

12.4 Fludeoxyglucose (18F) Radionuclide Injection Market Forecast by Application (2018-2023)

12.4.1 Global Fludeoxyglucose (18F) Radionuclide Injection Sales Forecast by Application (2018-2023)

12.4.2 Global Fludeoxyglucose (18F) Radionuclide Injection Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Fludeoxyglucose (18F) Radionuclide Injection Picture

Table Product Specifications of Fludeoxyglucose (18F) Radionuclide Injection

Figure Global Sales Market Share of

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery